Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt
Merck

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR JANUVIA

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Januvia

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00086502 Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus Completed Merck Sharp & Dohme Corp. Phase 3 2004-06-01 The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00086515 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2004-06-01 The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00087516 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021) Completed Merck Sharp & Dohme Corp. Phase 3 2004-06-01 The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Januvia

Condition Name

Condition Name for Januvia
Intervention Trials
Type 2 Diabetes Mellitus 34
Type 2 Diabetes 27
Diabetes Mellitus, Type 2 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Januvia
Intervention Trials
Diabetes Mellitus 86
Diabetes Mellitus, Type 2 81
Diabetes Mellitus, Type 1 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Januvia

Trials by Country

Trials by Country for Januvia
Location Trials
United States 234
Canada 13
Korea, Republic of 12
Italy 12
Mexico 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Januvia
Location Trials
Texas 16
California 13
Georgia 13
Ohio 13
Florida 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Januvia

Clinical Trial Phase

Clinical Trial Phase for Januvia
Clinical Trial Phase Trials
Phase 4 57
Phase 3 30
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Januvia
Clinical Trial Phase Trials
Completed 75
Recruiting 29
Unknown status 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Januvia

Sponsor Name

Sponsor Name for Januvia
Sponsor Trials
Merck Sharp & Dohme Corp. 41
Emory University 7
AstraZeneca 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Januvia
Sponsor Trials
Other 119
Industry 85
NIH 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Dow
Boehringer Ingelheim
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.